Patent directory · USPTO A61K / A61P
Patents matching “combination”
418 pharma patents match "combination" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 418 pharmaceutical patents matching "combination" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10576096
Tumor-selective combination therapy
granted -
US 10568873
Safranal-sorafenib combination therapy for liver cancer
granted -
US 2020040086
PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY
granted -
US 10544223
Combination therapy with an anti-axl antibody-drug conjugate
granted -
US 10532096
Methods and compositions comprising a combination of a VEGF antagonist and an anti-CTLA-4 antibody
granted -
US 10532056
Therapeutic compositions, combinations, and methods of use
granted -
US 10526414
Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases
granted -
US 10517860
Combination of pimavanserin and cytochrome P450 modulators
granted -
US 10500277
Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma
granted -
US 10493030
Combination HIV therapeutic
granted -
US 10485796
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted -
US 10478430
Compounds useful as inhibitors of ATR kinase and combination therapies thereof
granted -
US 10471144
Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
granted -
US 10471142
Combination therapy using immunoglobulin and C1-Inhibitor
granted -
US 10463654
Combination therapies for treating cancer
granted -
US 10463652
Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof
granted -
US 10456390
Combinations comprising MABA compounds and corticosteroids
granted -
US 10451610
Prediction of response to PARP inhibitors and combinational therapy targeting C-MET and PARP1
granted -
US 10434174
Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells
granted -
US 10434078
GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
granted -
US 10426786
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
granted -
US 10420812
Drug combinations and uses in treating a coughing condition
granted -
US 10406125
Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2O2 level in cancer cells of a subject
granted -
US 10376588
Etanercept formulations stabilized with combinations of sugars and polyols
granted